The latest findings report that in several tumors, including ovarian cancer, THY1 is overexpressed in cancer stem cells (CSC) and the tumor microenvironment, enhancing proliferation and metastasis abilities [7]. This evidence concerns the gene THY1 and ovarian carcinoma.